CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 114 filers reported holding CHEMOCENTRYX INC in Q2 2018. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,005,000 | -33.4% | 19,455 | -68.0% | 0.06% | -46.0% |
| Q2 2022 | $1,508,000 | +326.0% | 60,875 | +330.7% | 0.11% | +391.3% |
| Q1 2022 | $354,000 | +14.9% | 14,135 | +84.3% | 0.02% | -82.3% |
| Q1 2020 | $308,000 | +31.6% | 7,669 | -77.7% | 0.13% | +49.4% |
| Q3 2019 | $234,000 | -9.7% | 34,460 | +23.7% | 0.09% | -9.4% |
| Q2 2019 | $259,000 | +48.9% | 27,860 | +122.4% | 0.10% | -3.0% |
| Q1 2019 | $174,000 | -79.5% | 12,526 | -83.9% | 0.10% | -58.1% |
| Q4 2018 | $847,000 | -34.5% | 77,671 | -24.1% | 0.24% | -15.4% |
| Q3 2018 | $1,293,000 | +2.5% | 102,281 | +6.8% | 0.28% | +6.5% |
| Q2 2018 | $1,261,000 | – | 95,784 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,796,516 | $45,142,000 | 7.90% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $5,790,000 | 4.09% |
| Belmont Global Advisors, Inc. | 175,000 | $1,013,000 | 0.82% |
| Broadfin Capital, LLC | 1,033,668 | $5,985,000 | 0.79% |
| WASATCH ADVISORS LP | 2,650,551 | $15,347,000 | 0.15% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,158,613 | $6,708,000 | 0.09% |
| Artal Group S.A. | 275,000 | $1,592,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 41,355 | $239,000 | 0.05% |
| A.R.T. Advisors, LLC | 33,501 | $193,000 | 0.01% |
| BANQUE PICTET & CIE SA | 50,932 | $295,000 | 0.01% |